People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Opko Health, Inc. | — | Pharmaceuticals | Series D+ | $206.0M | $6.2B | 2013 |
Alice Lin-Tsing C. Yu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alice Lin-Tsing C. Yu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven D. Rubin | 1 | 9 |
| JANE H HSIAO | 1 | 5 |
| Richard C. Pfenniger, Jr. | 1 | 4 |
| Richard A. Lerner | 1 | 4 |
| Phillip Frost | 1 | 3 |
| Dmitry A. Kolosov | 1 | 1 |
| Pascal J. Goldschmidt | 1 | 1 |
| Naveed K Shams | 1 | 1 |
| Rao Uppaluri | 1 | 1 |
| Alice Lin-Tsing Yu | 1 | 1 |
| Juan F. Rodriguez | 1 | 1 |
| Thomas E. Beier | 1 | 1 |
| John A. Paganelli | 1 | 1 |
| Robert A. Baron | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.